Position in AZN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$550,824,481
New position
Shares Held
2,904,886
first reported quarter
Ownership
0.187%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#53
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 79%
Shared 13%
None 8%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $19,386,650,383 across 15 Drug Manufacturers - General names. AZN ranks #10 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,003,417 | $4,801,818,850 | |
| 2 | JNJ |
Johnson & Johnson
|
15,385,556 | $3,907,469,656 | |
| 3 | MRK |
Merck & Co., Inc.
|
17,486,486 | $2,247,013,450 | |
| 4 | ABBV |
AbbVie Inc.
|
7,236,861 | $1,821,083,699 | |
| 5 | NVS |
Novartis AG
|
8,117,586 | $1,272,188,077 | |
| 6 | AMGN |
Amgen Inc
|
3,413,981 | $1,236,270,798 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
19,691,951 | $1,134,650,214 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
7,899,794 | $998,059,971 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $550,824,481 | 2,904,886 | Shares | Sole | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||